Nevertheless, researches have proven that gemcitabine have limitation benefits in clinical because of the chemo-resistant and the curative effect of many new treatment options such as S-1, FOLFIRINOX or gemcitabine plus nanoparticle albumin-bound paclitaxel were better than gemcitabine [3,33,34]. ...